Scinai Immunotherapeutics Ltd. Quarterly Operating Lease, Liability in USD from Q4 2022 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Scinai Immunotherapeutics Ltd. quarterly Operating Lease, Liability history and growth rate from Q4 2022 to Q1 2023.
Scinai Immunotherapeutics Ltd. Operating Lease, Liability for the quarter ending March 31, 2023 was $420K.

Operating Lease, Liability, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$420K			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$382K			Dec 31, 2022	10-Q	2023-05-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.